These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9027788)

  • 1. Pharmacokinetics of carboplatin and etoposide in a haemodialysis patient with Merkel-cell carcinoma.
    Suzuki S; Koide M; Sakamoto S; Matsuo T
    Nephrol Dial Transplant; 1997 Jan; 12(1):137-40. PubMed ID: 9027788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.
    English MW; Lowis SP; Peng B; Boddy A; Newell DR; Price L; Pearson AD
    Br J Cancer; 1996 Mar; 73(6):776-80. PubMed ID: 8611379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy with carboplatin and etoposide against lung adenocarcinoma in a patient undergoing hemodialysis: a case report].
    Yanagawa H; Takishita Y; Bando H; Shinohara T; Tanaka H; Sumitani H
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2409-11. PubMed ID: 8259862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity.
    Wright JE; Elias A; Tretyakov O; Holden S; Andersen J; Wheeler C; Schwartz G; Antman K; Rosowsky A; Frel E
    Cancer Chemother Pharmacol; 1995; 36(4):345-51. PubMed ID: 7628055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic analysis of carboplatin and etoposide in a small cell lung cancer patient undergoing hemodialysis.
    Takezawa K; Okamoto I; Fukuoka M; Nakagawa K
    J Thorac Oncol; 2008 Sep; 3(9):1073-5. PubMed ID: 18758316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients.
    Veal GJ; Cole M; Errington J; Pearson AD; Gerrard M; Whyman G; Ellershaw C; Boddy AV
    Cancer Chemother Pharmacol; 2010 May; 65(6):1057-66. PubMed ID: 19701749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboplatin pharmacokinetics in a patient receiving hemodialysis.
    Fong MK; Fetterly GJ; McDougald LJ; Iyer RV
    Pharmacotherapy; 2014 Feb; 34(2):e9-13. PubMed ID: 24037992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for Merkel cell carcinoma with carboplatin and etoposide.
    Pectasides D; Moutzourides G; Dimitriadis M; Varthalitis J; Athanassiou A
    Am J Clin Oncol; 1995 Oct; 18(5):418-20. PubMed ID: 7572759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy.
    Morikawa N; Mori T; Abe T; Kawashima H; Takeyama M; Hori S
    Biol Pharm Bull; 1999 Apr; 22(4):428-31. PubMed ID: 10328568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma.
    Newell DR; Eeles RA; Gumbrell LA; Boxall FE; Horwich A; Calvert AH
    Cancer Chemother Pharmacol; 1989; 23(6):367-72. PubMed ID: 2469544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel and carboplatin combination chemotherapy in a hemodialysis patient with advanced ovarian cancer.
    Watanabe M; Aoki Y; Tomita M; Sato T; Takaki Y; Kato N; Kikuchi M; Kase H; Tanaka K
    Gynecol Oncol; 2002 Feb; 84(2):335-8. PubMed ID: 11812097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Merkel Cell Carcinoma Complicated with Severe Thrombocytopenia Treated with Carboplatin/Etoposide Regimen after Surgery].
    Saito Y; Kiba T; Takahashi T; Hirakawa H; Saito M; Otomo C; Sato M; Watanabe Y; Sakaguchi M; Kadota R; Noguchi N; Suzuki T; Awataguchi T; Shoji F; Ota N
    Gan To Kagaku Ryoho; 2017 Aug; 44(8):685-687. PubMed ID: 28860441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.
    Porter D; Boddy A; Thomas H; Lind M; Newell D; Calvert AH; Robson L; Brampton M; Abrahamsen D; Winograd B
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):34-44. PubMed ID: 8996574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer.
    Rudin CM; Kozloff M; Hoffman PC; Edelman MJ; Karnauskas R; Tomek R; Szeto L; Vokes EE
    J Clin Oncol; 2004 Mar; 22(6):1110-7. PubMed ID: 15020613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07.
    Poulsen M; Rischin D; Walpole E; Harvey J; Mackintosh J; Ainslie J; Hamilton C; Keller J; Tripcony L;
    J Clin Oncol; 2003 Dec; 21(23):4371-6. PubMed ID: 14645427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
    Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D
    Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency.
    Motzer RJ; Niedzwiecki D; Isaacs M; Menendez-Botet C; Tong WP; Flombaum C; Scher HI; Bosl GJ
    Cancer Chemother Pharmacol; 1990; 27(3):234-8. PubMed ID: 2176133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.
    Duong JK; Veal GJ; Nath CE; Shaw PJ; Errington J; Ladenstein R; Boddy AV
    Br J Clin Pharmacol; 2019 Jan; 85(1):136-146. PubMed ID: 30261554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer.
    Okamoto H; Watanabe K; Nishiwaki Y; Mori K; Kurita Y; Hayashi I; Masutani M; Nakata K; Tsuchiya S; Isobe H; Saijo N
    J Clin Oncol; 1999 Nov; 17(11):3540-5. PubMed ID: 10550152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study and clinical pharmacological evaluation of daily oral etoposide combined with carboplatin in patients with lung cancer.
    Ohune T; Fujiwara Y; Sumiyoshi H; Yamaoka N; Yamakido M
    Jpn J Cancer Res; 1995 May; 86(5):490-500. PubMed ID: 7790322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.